Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | 33.14%105.62M | 35.75M | 33.92M | 106.42%79.33M | 146.56%38.43M | 7,740.20%15.59M | -204K |
| Net profit before non-cash adjustment | 45.05%83.44M | --24.42M | --23.5M | 109.45%57.52M | 121.60%27.46M | 2,698.11%12.39M | ---477K |
| Total adjustment of non-cash items | 28.76%27.81M | --7.74M | --6.85M | 77.17%21.6M | 261.14%12.19M | 495.41%3.38M | --567K |
| -Depreciation and amortization | 52.99%29.54M | --8.55M | --7.83M | 84.51%19.31M | 249.00%10.46M | 486.69%3M | --511K |
| -Reversal of impairment losses recognized in profit and loss | --177K | ---- | ---- | --0 | --212K | --0 | --0 |
| -Share of associates | -407.14%-172K | ---150K | ---45K | --56K | --0 | --0 | --0 |
| -Disposal profit | ---2.16M | ---1.07M | ---1.09M | --0 | --0 | --0 | --0 |
| -Other non-cash items | -80.93%427K | --230K | --148K | 47.59%2.24M | 301.32%1.52M | 575.00%378K | --56K |
| Changes in working capital | -2,859.80%-5.63M | --3.6M | --3.57M | 116.64%204K | -569.95%-1.23M | 37.76%-183K | ---294K |
| -Change in receivables | -163.01%-11.5M | ---4.81M | ---2.9M | 23.14%-4.37M | -91.36%-5.69M | -499.60%-2.97M | ---496K |
| -Change in inventory | -9.78%-5.29M | ---830K | --673K | -274.49%-4.82M | -96.34%-1.29M | -294.58%-655K | ---166K |
| -Change in payables | 17.66%10.65M | --8.92M | --5.6M | 57.35%9.05M | 66.89%5.75M | 836.41%3.45M | --368K |
| -Changes in other current assets | 48.99%514K | --310K | ---- | --345K | --0 | --0 | --0 |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | |||||||
| Interest received (cash flow from operating activities) | |||||||
| Tax refund paid | -112.00%-23.81M | -7.26M | -11.21M | -285.19%-11.23M | -2.92M | 0 | 0 |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 20.14%81.81M | --28.49M | --22.71M | 91.74%68.09M | 127.85%35.51M | 7,740.20%15.59M | ---204K |
| Investing cash flow | |||||||
| Net PPE purchase and sale | -85.93%-31.81M | ---10.26M | ---10.9M | -25.45%-17.11M | -148.72%-13.64M | -154.12%-5.48M | ---2.16M |
| Net business purchase and sale | 3.13%-991K | --0 | ---- | ---1.02M | --0 | --0 | --0 |
| Net investment product transactions | ---100.14M | --38.44M | ---- | ---- | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | --0 | -2,221.82%-1.28M | ---55K |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | 33,100.00%1.33M | --4K | ---- |
| Interest received (cash flow from investment activities) | 304.44%3.74M | --829K | --965K | 689.74%924K | --117K | --0 | --0 |
| Investing cash flow | -650.77%-129.21M | --29.01M | ---149.51M | -41.12%-17.21M | -80.48%-12.2M | -205.33%-6.76M | ---2.21M |
| Financing cash flow | |||||||
| Net common stock issuance | 43,935.14%179.22M | --0 | --0 | -89.58%407K | -57.49%3.91M | 819.00%9.19M | --1M |
| Increase or decrease of lease financing | -51.00%-16.45M | ---4.82M | ---4.23M | -95.76%-10.89M | -249.06%-5.56M | -810.86%-1.59M | ---175K |
| Cash dividends paid | -600.00%-21M | --0 | --0 | 62.59%-3M | -215.62%-8.02M | ---2.54M | ---- |
| Interest paid (cash flow from financing activities) | -32.90%-4.28M | ---1.18M | ---1.11M | -104.96%-3.22M | -315.87%-1.57M | -575.00%-378K | ---56K |
| Net other fund-raising expenses | 72.22%-5K | --0 | ---4K | 96.57%-18K | 64.86%-525K | -176.77%-1.49M | --1.95M |
| Financing cash flow | 922.06%137.49M | ---6M | ---5.35M | -42.05%-16.73M | -469.90%-11.77M | 17.24%3.18M | --2.72M |
| Net cash flow | |||||||
| Beginning cash position | 137.74%58.96M | --97.53M | --229.69M | 87.09%24.8M | 966.37%13.26M | 31.53%1.24M | --945K |
| Current changes in cash | 163.73%90.09M | --51.5M | ---132.15M | 195.90%34.16M | -3.90%11.54M | 3,930.87%12.01M | --298K |
| Effect of exchange rate changes | --0 | --14K | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 152.80%149.05M | --149.05M | --97.53M | 137.74%58.96M | 87.09%24.8M | 966.37%13.26M | --1.24M |
| Free cash flow | -2.08%49.93M | --18.23M | --11.76M | 133.09%50.98M | 116.52%21.87M | 527.69%10.1M | ---2.36M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.